Psoriasis treatment 2020

ABSTRACT: Infliximab is a TNFα inhibiting recombinant monoclonal antibody, which provides an efficient therapeutic opportunity in the treatment of psoriasis and other immune-mediated inflammatory diseases.

copd lelki okai

It is well tolerated and improves quality of life significantly. The authors present a case of drug-induced lupus erythematosus as a possible side effect of this psoriasis treatment 2020.

vörös foltok viszketnek a lábak között

The patient developed psoriasis 9 years ago when she was on beta-receptor blocker therapy. The symptoms deteriorated despite topical and systemic treatments and, therefore, biological therapy was introduced.

pikkelysömör kezelése new

In the third year of treatment drug-induced lupus erythematosus was diagnosed on the background of general symptoms. After cessation of the biologic treatment a low dose corticosteroid therapy was introduced which proved to be effective.

Symptoms as well as pathological laboratory parameters showed an improvement.

mi a pikkelysömör hogyan kell kezelni otthon

The authors conclude that biologicals are effective and safe in the treatment of psoriasis, nevertheless, they have risks too. To reduce side effects a meticulous follow-up of patients is essential.

pikkelysömör milyen gyógyszert inni

Any general symptom requires careful examination since they might be linked to serious side effects of the biological therapy.